EGFR and non-small cell lung carcinoma: Longitudinal Monitoring of <i>EGFR</i> and <i>PIK3CA</i> Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports.